MACULO-Cell™ is a high-purity cellular therapy product created by suspending 5 million Mesenchymal Stem Cells (MSCs) isolated from Wharton's Jelly (WJ) cord tissue in 2-5 ml of physiological saline. This suspension, specifically formulated to meet the patient's clinical needs, has a live cell content optimized for tissue repair and regeneration.

​

Mechanism of Action

MACULO-Cell™ performs biological repair in eye tissues through the following mechanisms thanks to its neuroprotective and neuroregenerative properties:

​

Anti-Apoptosis: Inhibits apoptosis (programmed cell death) of photoreceptor cells that detect light in the eye; thus aiming to slow the progression of vision loss.

​

Retinal and Corneal Repair: Helps reduce retinal damage while preventing corneal scarring (wound tissue) that can impair vision.

​

Inflammation Control: With its strong anti-inflammatory effect, it plays a significant role in halting the progression of eye inflammation-related diseases and in the treatment process.

​

​

Application Method

MACULO-Cell™ is recommended as a supportive treatment for conditions such as hereditary retinal and optic nerve disorders, macular dystrophy, night blindness, macular degeneration, high eye pressure, and chronic non-resolving eye diseases; it is applied locally or systemically under the supervision of a specialist physician.